Sentiment · ABBV
Lobbying Spend for ABBV
AI-generated plain-English read of lobbying spend for ABBV. Updated daily.
Heavy lobbying, trending higher
highHeavy and rising. The company is building a more serious DC presence quarter over quarter. Watch for a policy catalyst that would explain the ramp.
What will probably happen
- A rising trend without an obvious single catalyst suggests broadening DC engagement: a structural shift, not a one-quarter reaction.
- Spend is spread across many issue areas: the company has diverse regulatory exposure and is fighting on multiple fronts simultaneously.
What to do
- If you HOLD this stock
- Deepening DC engagement: hold your position but monitor the primary issue area for policy news that could catalyze a move in either direction.
- If you're EVALUATING this stock
- Heavy DC presence is a recurring cost and risk factor. Factor in the regulatory environment when sizing. Requires research into the primary issue areas.
- If you trade OPTIONS
- No clean options signal derived from this lobbying read.
9 quarters of history with $17.33M in total spend: sufficient data for a reliable trajectory read.
Technical details
Technical analysis
- Spend tier
- Heavy
- Trajectory
- Rising
- Issue concentration
- Broad
- Registrant base
- In house
- Last quarter
- $1.90M
- Last 4Q total
- $8.33M
- Prior 4Q total
- $7.42M
- Quarters on record
- 9
- Unique issue areas
- 8
- Unique registrants
- 14
- Top issue area
- COPYRIGHT/PATENT/TRADEMARK (58% of spend)
- Top registrant
- ABBVIE, INC. (71% of spend)
Key levels
| Level | Value |
|---|---|
| last quarter amount | 1,900,000 |
| last 4q total | 8,330,000 |
| prior 4q total | 7,420,000 |
| total amount | 17,330,000 |
| top issue pct | 0.575 |
| top registrant pct | 0.706 |
Caveats
- Lobbying disclosures are quarterly and reflect activity already past. The signal is structural, not timing.
- The primary registrant appears to be an in-house government-affairs operation. In-house lobbying may not be captured in full by third-party disclosure data.